Medical imaging software company Arterys has announced that its Oncology AI suite has...
Medical Device Single Audit Programme – Practical Training for Medical Device Manufactures
The MDSAP Medical Device Single Audit Programme Practical Training for Medical Device Manufacturers is taking place on 21 March.
MEDICARE TAIWAN and SenCARE Brochure
Taking place at the TaiPei World trade Center, MEDICARE TAIWAN and SenCARE medical and healthcare exhibitions will showcase products such as electromedical equipment, biopharmaceuticals, hospital equipment, dental products and medical robotics.
Benefits of Using a Contract Research Organisation for Medical Devices
Contract research organisations (CROs) are typically perceived as supporting medical device companies only with product testing and validation as part of their cGxP regulatory requirements. In reality they can do much more.
Tips for Choosing a Prototyping Machine Shop
Choosing the right prototyping machine shop for projects is an important decision in the entire process for entrepreneurs with little experience in dealing with CNC machine shops.
Arterys receives first FDA clearance for AI oncology imaging suite
Medical imaging software company Arterys has announced that its Oncology AI suite has received its fifth 510(k) clearance from the US Food and Drug Administration (FDA).
Human gut-on-a-chip could replace radiation testing on animals
An organ-on-a-chip model of the human gut could offer a better prediction of the effect of radiation exposure on humans than animal testing.
Smartphone app assists with correct interpretation of EGC reports
A new smartphone app assists with the correct interpretation of electrocardiogram (ECG) reports and could improve clinical training and reduce the risk of misdiagnosis and subsequent fatalities worldwide.
Nanorobots programmed to seek and destroy cancerous tumours
Scientists from Arizona State University (ASU) have successfully programmed nanorobots to shrink tumours by cutting off their blood supply. This study demonstrates the first application of DNA origami for nanomedicine.
MagForce to study NanoTherm therapy for prostate cancer in US
German firm MagForce and its MagForce USA division have obtained investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to study NanoTherm therapy as a focal ablation treatment in a clinical trial for intermediate risk prostate cancer.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.